Clinical Trial Update: Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating chemokine modulation therapy in combination with standard chemotherapy before surgery for early-stage triple-negative breast cancer; tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Carcinoma

Drugs mentioned

• Chemokine Modulation Therapy (null)
• Standard chemotherapy

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 1 | Status: COMPLETED | Results posted: 2023-09-11